A detailed history of Voya Investment Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 54,973 shares of TGTX stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,973
Previous 46,462 18.32%
Holding current value
$1.62 Million
Previous $826,000 55.57%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.21 - $25.28 $146,474 - $215,158
8,511 Added 18.32%
54,973 $1.29 Million
Q2 2024

Aug 14, 2024

BUY
$13.32 - $19.19 $12,334 - $17,769
926 Added 2.03%
46,462 $826,000
Q1 2024

May 15, 2024

SELL
$13.02 - $21.3 $123,065 - $201,327
-9,452 Reduced 17.19%
45,536 $692,000
Q4 2023

Feb 14, 2024

SELL
$6.68 - $18.81 $1.09 Million - $3.06 Million
-162,654 Reduced 74.73%
54,988 $939,000
Q3 2023

Nov 14, 2023

BUY
$8.36 - $26.5 $12,071 - $38,266
1,444 Added 0.67%
217,642 $1.82 Million
Q2 2023

Aug 14, 2023

BUY
$15.48 - $35.0 $2.55 Million - $5.76 Million
164,672 Added 319.59%
216,198 $5.37 Million
Q1 2023

May 15, 2023

SELL
$10.23 - $19.34 $5,575 - $10,540
-545 Reduced 1.05%
51,526 $774,000
Q4 2022

Feb 14, 2023

SELL
$5.01 - $11.83 $128,631 - $303,735
-25,675 Reduced 33.02%
52,071 $615,000
Q3 2022

Mar 03, 2023

BUY
$4.57 - $8.4 $117,334 - $215,670
25,675 Added 49.31%
77,746 $460,000
Q3 2022

Nov 14, 2022

SELL
$4.57 - $8.4 $4,780 - $8,786
-1,046 Reduced 1.33%
77,746 $460,000
Q2 2022

Aug 15, 2022

BUY
$3.74 - $10.66 $48,238 - $137,492
12,898 Added 19.57%
78,792 $335,000
Q1 2022

May 16, 2022

BUY
$7.81 - $20.45 $123,030 - $322,148
15,753 Added 31.42%
65,894 $627,000
Q4 2021

Feb 14, 2022

SELL
$15.2 - $35.51 $1.61 Million - $3.76 Million
-106,012 Reduced 67.89%
50,141 $953,000
Q3 2021

Nov 15, 2021

SELL
$21.78 - $40.45 $212,006 - $393,740
-9,734 Reduced 5.87%
156,153 $5.2 Million
Q2 2021

Aug 16, 2021

SELL
$32.5 - $48.96 $216,027 - $325,437
-6,647 Reduced 3.85%
165,887 $6.44 Million
Q1 2021

May 17, 2021

SELL
$41.61 - $54.3 $701,128 - $914,955
-16,850 Reduced 8.9%
172,534 $8.32 Million
Q4 2020

Feb 16, 2021

BUY
$25.27 - $54.9 $3.7 Million - $8.04 Million
146,408 Added 340.67%
189,384 $9.85 Million
Q3 2020

Nov 16, 2020

BUY
$18.49 - $27.24 $176,006 - $259,297
9,519 Added 28.45%
42,976 $1.15 Million
Q2 2020

Aug 14, 2020

SELL
$8.9 - $21.84 $84,541 - $207,458
-9,499 Reduced 22.11%
33,457 $652,000
Q1 2020

May 15, 2020

BUY
$7.14 - $15.99 $8,325 - $18,644
1,166 Added 2.79%
42,956 $423,000
Q4 2019

Feb 14, 2020

BUY
$5.1 - $11.2 $64,244 - $141,086
12,597 Added 43.15%
41,790 $464,000
Q2 2019

Aug 14, 2019

BUY
$6.27 - $8.65 $16,765 - $23,130
2,674 Added 10.08%
29,193 $253,000
Q4 2018

Feb 14, 2019

BUY
$3.44 - $5.76 $10,141 - $16,980
2,948 Added 12.51%
26,519 $109,000
Q2 2018

Aug 14, 2018

BUY
$12.5 - $15.0 $13,125 - $15,750
1,050 Added 4.66%
23,571 $310,000
Q3 2017

Nov 14, 2017

BUY
$10.0 - $12.7 $225,210 - $286,016
22,521
22,521 $267,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.